Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L McClean

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Healthcare Technology Letters|December 14, 2022
Alzheimer's disease classification using cluster-based labelling for graph neural network on heterogeneous dataNiamh McCombe, Jake Bamrah, Jose M Sanchez-Bornot, et al.
Diabetologia|May 9, 2007
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob miceN Irwin, P L McClean, F P M O'Harte, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat dietPaula L McClean, Nigel Irwin, Roslyn S Cassidy, et al.
Neuropharmacology|May 8, 2020
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's diseaseAlok Joshi, Da-Hui Wang, Steven Watterson, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Graph-BrainConvNet: A One-class GCN-based approach for MCI detection from source-level MEGKaniska Samanta, Jose Miguel Sanchez-Bornot, Paula L McClean, et al.
Emerging Infectious Diseases|April 15, 2005
Ross River virus disease reemergence, Fiji, 2003-2004Philipp Klapsing, J Dick MacLean, Sarah Glaze, et al.
British Poultry Science|June 30, 2004
Protein turnover in chicken skeletal muscle: understanding protein dynamics on a proteome-wide scaleM K Doherty, L McClean, I Edwards, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|September 10, 2022
Multiple Cost Optimisation for Alzheimer's Disease DiagnosisNiamh McCombe, Xuemei Ding, Girijesh Prasad, et al.
Neuromolecular Medicine|September 27, 2012
The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's diseaseCaitriona M Long-Smith, Sean Manning, Paula L McClean, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2026
A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairmentGillian McNaugher, Leah McColgan, Mia Church, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Healthcare Technology Letters|December 14, 2022
Alzheimer's disease classification using cluster-based labelling for graph neural network on heterogeneous dataNiamh McCombe, Jake Bamrah, Jose M Sanchez-Bornot, et al.
Diabetologia|May 9, 2007
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob miceN Irwin, P L McClean, F P M O'Harte, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat dietPaula L McClean, Nigel Irwin, Roslyn S Cassidy, et al.
Neuropharmacology|May 8, 2020
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's diseaseAlok Joshi, Da-Hui Wang, Steven Watterson, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 3, 2025
Graph-BrainConvNet: A One-class GCN-based approach for MCI detection from source-level MEGKaniska Samanta, Jose Miguel Sanchez-Bornot, Paula L McClean, et al.
Emerging Infectious Diseases|April 15, 2005
Ross River virus disease reemergence, Fiji, 2003-2004Philipp Klapsing, J Dick MacLean, Sarah Glaze, et al.
British Poultry Science|June 30, 2004
Protein turnover in chicken skeletal muscle: understanding protein dynamics on a proteome-wide scaleM K Doherty, L McClean, I Edwards, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|September 10, 2022
Multiple Cost Optimisation for Alzheimer's Disease DiagnosisNiamh McCombe, Xuemei Ding, Girijesh Prasad, et al.
Neuromolecular Medicine|September 27, 2012
The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-β plaque and glial pathology in a mouse model of Alzheimer's diseaseCaitriona M Long-Smith, Sean Manning, Paula L McClean, et al.
Journal of Alzheimer'S Disease : JAD|June 6, 2026
A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairmentGillian McNaugher, Leah McColgan, Mia Church, et al.
Pageof 8